Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
These results suggested that Sal A enhanced the homocysteine removal via its transsulfuration to cysteine in hyperlipidemic rats by means of increasing CBS activity
Complete response letters have become uncommon for obesity drugs with large, well-run trial programs (FDA CDER)
Ethics declarations Conflict of interest During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article
This medicalization of obesity, along with aggressive pharmaceutical marketing, raises ethical questions about commercial influences on prescribing practices
US$ 22.99
US$ 28.59
